2011
Asselin, BL. "L-Asparaginase for Treatment of Childhood Acute Lymphoblastic Leukemia: What Have We Learned?". Pediatric Blood Cancer. 2011; .
|
2010
Silverman, LB; Stevenson, K; O'Brien, JE; Asselin, BL; Athale, UH; Clavell, L; Cole, PD; Kelly, K; Laverdiere, C; Michon, B; Schorin, M; Schwartz, CL; Whyte, O'Holleran, E; Neuberg, DS; Cohen, HJ; Sallan, SE. "Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)". Leukemia. 2010; 24: 320-334.
|
2010
Brooman, LM; Supko, J; Neuberg, DS; Asselin, BL; Athale, UH, Clavell, L; Kelly, K; Laverdiere, C; Michon, B; Schorin, M; Sallan, SE; Silverman, LB. "Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia: pharmacodynamics and tolerability." Pediatric Blood and Cancer. 2010; 54: 199-205.
|
2010
Silverman, LB; Supko, JG; Stevenson, KE; Woodward, C; Vrooman, LM; Neuberg, DS; Asselin, BL; Athale, UH; Cole, PD; Kelly, KM; Laverdiere, C; Michon, B; Schorin, M; Schwartz, CL; O'Brien, JE; Cohen HJ; Sallan, SE. "Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia." Blood. 2010; 115(7): 1351-53.
|
2010
Vrooman, LM; Neuberg, DS; Supko, JG; Kutok, JL; Dahlberg, S; Stevenson, K; O'Brien, J; Asselin, BL; Athale, UH; Clavell, L; Kelly, KM; Laverdiere, C; Lipshultz, SE; Michon, B; Schorin, M; Cohen, HJ; Sallan, SE; Silverman, LB. "Efficacy of Individualized Dosing of L-Asparaginase and Dexamethasone in Children and Adolescents with Newly Diagnosed Acute Lymphoblastic Leukemia: Results from the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocol 00-01." Submitted to Blood. 2010; .
|
2010
Asselin, BL; Devidas, M; Wang, C; Pullen, J; Borowitz, MJ; Hutchison, R; Lipshultz, S; Camitta, BM. "Effectiveness of High Dose Methotrexate in T-cell Lymphoblastic Leukemia and Advanced Stage Lymphoblastic Lymphoma: A Randomized Study by the Children's Oncology Group (POG 9404)". Submitted to Blood. 2010; .
|
2010
Lipshultz SE; Scully RE; Lipsitz SR; Sallan SE; Silverman LB; Miller TL; Barry EV; Asselin BL; Athale U; Clavell LA; Larsen E; Moghrabi A; Samson Y; Michon B; Schorin MA; Cohen HJ; Neuberg DS; Orav EJ; Colan SD. "Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukemia: long-term follow-up of a prospective, randomized, multicentre trial." Lancet Oncol. 2010; 11: 950-61.
|
2010
Asselin, BL; Devidas, M; Wang, C; Pullen, J; Borowitz, MJ; Hutchison, R; Lipshultz, S; Camitta, BM. "Effectiveness of High Dose Methotrexate in T-cell Lymphoblastic Leukemia and Advanced Stage Lymphoblastic Lymphoma: A Randomized Study by the Children's Oncology Group (POG 9404)". Blood. 2010; doi:10.1182/blood-2010-06-292615.
|
2008 Mar 1
Barry EV, Vrooman LM, Dahlberg SE, Neuberg DS, Asselin BL, Athale UH, Clavell LA, Larsen EC, Moghrabi A, Samson Y, Schorin MA, Cohen HJ, Lipshultz SE, Sallan SE, Silverman LB. "Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2008 Mar 1; 26(7):1106-11.
|
2007 Sep 1
Winter SS, Jiang Z, Khawaja HM, Griffin T, Devidas M, Asselin BL, Larson RS, . "Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group." Blood. 2007 Sep 1; 110(5):1429-38. Epub 2007 May 10.
|
2007 Mar 1
Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Cohen HJ, Sallan SE, Silverman LB. "Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2007 Mar 1; 25(7):813-9.
|
2007 Feb
Moghrabi A, Levy DE, Asselin BL, Barr R, Clavell L, Hurwitz C, Samson Y, Schorin M, Dalton VK, Lipshultz SE, Neuberg DS, Gelberg RD, Cohen HJ. "Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia." Blood First Editioin Paper, prepublished online Sept 26, 2006. DOI 10.1182/blood-206-06-027714. 2007; 109(3): 896-904.
|
2007
Salzer WL, Devias M, Shuster JJ, Wang C, Chauvenet A, Asselin BL, Camitta BM and Kurtzberg J. "Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymhoblastic leukemia: a report from the Children's Oncology Group." J Pediatr Hematol/Oncol. 2007; 29(6): 369-375.
|
2007
Avramis VI, Martin-Aragon S, Avramis EV, Asselin BL. "Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models." Anticancer research. 2007 27(4C):2561-72.
|
2005 Nov 1
Basu SK, Fernandez ID, Fisher SG, Asselin BL, Lyman GH. "Length of stay and mortality associated with febrile neutropenia among children with cancer." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2005 Nov 1; 23(31):7958-66.
|
2004 Jul 8
Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR, Colan SD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE. "The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia." The New England journal of medicine. 2004 Jul 8; 351(2):145-53.
|
2003 Oct 1
Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL. "Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2003 Oct 1; 21(19):3616-22.
|
2003 Aug 1
Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Tarbell NJ, Sallan SE, Cohen LE. "Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2003 Aug 1; 21(15):2953-60.
|
2002 Mar 15
Lipshultz SE, Giantris AL, Lipsitz SR, Kimball Dalton V, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE, Colan SD. "Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2002 Mar 15; 20(6):1677-82.
|
2002 Jan 1
LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE. "Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2002 Jan 1; 20(1):237-46.
|
2001 Mar 1
Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Arkin S, Declerck L, Cohen HJ, Sallan SE. "Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01." Blood. 2001 Mar 1; 97(5):1211-8.
|
2000
Silverman LB, Declerck L, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Lipton JM, Cohen HJ, Sallan SE. "Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)." Leukemia : official journal of the Leukemia Society of America,
Leukemia Research Fund, U.K. 2000 14(12):2247-56.
|
1999
Asselin BL, Kreissman S, Coppola DJ, Bernal SD, Leavitt PR, Gelber RD, Sallan SE, Cohen HJ. "Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia." Journal of pediatric hematology/oncology : official journal of the
American Society of Pediatric Hematology/Oncology. 1999 21(1):6-12.
|
1999
Asselin BL. "The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia." Advances in experimental medicine and biology. 1999 457:621-9.
|
1998 May
Graham ML, Asselin BL, Herndon JE, Casey JR, Chaffee S, Ciocci GH, Daeschner CW, Davis AR, Gold S, Halperin EC, Laughlin MJ, Martin PL, Olson JF, Kurtzberg J. "Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia." Bone marrow transplantation. 1998 May 0; 21(9):879-85.
|
1998 Jan
Giantris A, Abdurrahman L, Hinkle A, Asselin BL, Lipshultz S. "Anthracycline Induced Cardiotoxicity". Critical Reviews in Oncology-Hematology. 1998; 27: 53-68.
|
1997
Snitzer EL, Fultz PJ, Asselin B. "Magnetic resonance imaging appearance of fibromatosis colli." Magnetic resonance imaging. 1997 15(7):869-71.
|
1996 Jun
Asselin BL. "Pegaspargase: A viewpoint". Clin Therapeutics. 1996; 5: 497-498.
|
1996 Jun
Korones DN, Buzzard CJ, Asselin BL, Harris JP. "Right atrial thrombi in children with cancer and indwelling catheters." The Journal of pediatrics. 1996 Jun 0; 128(6):841-6.
|
1993 Sep
Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HJ. "Comparative pharmacokinetic studies of three asparaginase preparations." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1993 Sep 0; 11(9):1780-6.
|
1992 Mar 13
Asselin BL. "Evaluation of tumor cell heterogeneity based on response to chemotherapy." Clinica chimica acta; international journal of clinical
chemistry. 1992 Mar 13; 206(1-2):33-44.
|
1992
Stephens R, Asselin BL. "Application of the MTT assay to chemosensitivity testing using human leukemic cell lines". Journal Univ Rochester Medical Center. 1992; 3((2)).
|
1991
Asselin BL, Lorenson MY, Whitin JC, Coppola DJ, Kende AS, Blakley RL, Cohen HJ. "Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor." Cancer research. 1991 51(24):6568-73.
|
1990 Apr
Asselin BL. "Clinical use of intravenous immunoglobulin". Hospital Therapy. 1990; 15((4)): 479-439.
|
1990
Rupp IP*, Asselin BL, Whitin JC, Cohen HJ. "Clearance of L-asparaginase enzyme activity and protein". Journal Univ Rochester Medical Center. 1990; 2((2)): 2-5.
|
1989 Aug 1
Asselin BL, Ryan D, Frantz CN, Bernal SD, Leavitt P, Sallan SE, Cohen HJ. "In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase." Cancer research. 1989 Aug 1; 49(15):4363-8.
|
1987 Mar
Asselin BL, Lawrence RA. "Maternal disease as a consideration in lactation management." Clinics in perinatology. 1987 Mar 0; 14(1):71-87.
|
0
Vrooman, ML; Neuberg, DS; Stevenson, KE; Asselin, BL; Athale, UH; Clavell, L; Cole, PD; Kelly, KM; Laverdiere, C; Michon, B; Schorin, M; Schwartz, CL; Cohen, HJ; Lipshultz, SE; Silverman, LB; Sallan, SE. "The Rarity of Second Malignant Neoplasms Associated with Dexrazoxane in Children Treated for Acute Lymphoblastic Leukemia; a Report from the Dana-Farber Cancer Institute ALL Consortium". J Clin Oncol. .
|
0
Lipshultz, SE; Miller, TL; Lipsitz, SR; Neuberg, DS; Dahlberg, SE; Colan, SD; Silverman, LB; Henkel, JM; Cushman, LL; Asselin, BL; Clavell, LA; Athale, U; Michon, B; Laverdiere, C; Schorin, MA; Larsen, E; Usmani, N; Sallan, SE, for the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. "Late Cardiac Status in Long-Term Survivors of Childhood High-Risk Acute Lymphoblastic Leukemia 8 Years After Continuous or Bolus Infusion of Doxorubicin: The Dana-Farber Canancer Institute ALL 91-01 Randomized Trial". J Clin Oncol. Accepted 2011.
|
